HIV-1 matrix mutations that alter gag membrane binding modulate mature core formation and post-entry events.
Cell Line, Tumor
Cell Membrane
/ metabolism
Gene Expression
HEK293 Cells
HIV-1
/ genetics
Humans
Lymphocytes
/ metabolism
Mutation
Protein Binding
Protein Domains
Protein Precursors
/ chemistry
Reverse Transcription
Viral Matrix Proteins
/ chemistry
Virion
/ genetics
Virus Assembly
/ genetics
Virus Integration
/ genetics
Virus Replication
/ genetics
gag Gene Products, Human Immunodeficiency Virus
/ chemistry
Core formation
Gag
HIV-1
Integration
Matrix
Membrane binding
Post entry
Reverse transcription
Uncoating
Journal
Virology
ISSN: 1096-0341
Titre abrégé: Virology
Pays: United States
ID NLM: 0110674
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
29
03
2019
revised:
24
04
2019
accepted:
25
04
2019
pubmed:
6
5
2019
medline:
8
7
2020
entrez:
6
5
2019
Statut:
ppublish
Résumé
The matrix (MA) domain of HIV-1 Gag directs membrane binding of the Gag precursor polyprotein during the late events of virus replication. However, the effects of alteration in Gag membrane binding early post-infection are not well understood. To investigate impacts of MA mutations that alter Gag membrane binding on the phenotypes of newly produced virus particles, we extensively characterized two MA mutants by virological, biochemical, and morphological approaches. The V6R mutation, which decreases Gag membrane binding, modified Gag processing and core morphogenesis and impaired core uncoating, reverse transcription, and viral DNA integration. On the other hand, the L20K mutation, which increases Gag membrane binding, primarily decreased integrated DNA levels without affecting the viral components and morphology. These data suggest that HIV-1 MA plays roles in functional core formation and the following post-entry steps of the virus replication cycle. (140/150 words).
Identifiants
pubmed: 31055063
pii: S0042-6822(19)30113-8
doi: 10.1016/j.virol.2019.04.013
pii:
doi:
Substances chimiques
Protein Precursors
0
Viral Matrix Proteins
0
gag Gene Products, Human Immunodeficiency Virus
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
97-107Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.